Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, and surprise medical billing. H.R.2389/S.1302, Resident Physician Shortage Reduction Act of 2023.
Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters.
Duration: January 1, 2018
to
present
General Issues: Medicare/Medicaid , Medical/Disease Research/Clinical Labs
Spending: about $840,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2018: U.S. Senate, House of Representatives, White House Office, Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Billy Wynne Health Policy Counsel, Senate Finance Committee
Katie Pahner Health Insurance Specialist, Ctrs. for Medicare/Medicaid Svc
Kristen O'Neill Health Policy Advisor, Legislative Assistant, Staff Asst, Rep. Gene Green; Staff Asst, Rep. G.K. Butterfield
Geoff Werth Rep. Bart Stupak, Senior Legislative Assistant; Minority Leader Dick Gephardt, Policy Advisor
Lauren Testa n/a
Alyson Lewis n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Impact Health Policy Partners lobbied for Hackensack Meridian Health , earning $40,000. The report was filed on April 18.
Original Filing: 301552755.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, and surprise medical billing. H.R.2389/S.1302, Resident Physician Shortage Reduction Act of 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2023
In Q4, Impact Health Policy Partners lobbied for Hackensack Meridian Health , earning $40,000. The report was filed on Jan. 18.
Original Filing: 301527661.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, and surprise medical billing. H.R.2389/S.1302, Resident Physician Shortage Reduction Act of 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2023
In Q3, Impact Health Policy Partners lobbied for Hackensack Meridian Health , earning $40,000. The report was filed on Oct. 17, 2023.
Original Filing: 301502155.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, and surprise medical billing. H.R.2389/S.1302, Resident Physician Shortage Reduction Act of 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2023
In Q2, Impact Health Policy Partners (formerly known as Wynne Health Group) lobbied for Hackensack Meridian Health , earning $40,000. The report was filed on July 18, 2023.
Original Filing: 301479875.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, and surprise medical billing. H.R.2389/S.1302, Resident Physician Shortage Reduction Act of 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2023
In Q1, Wynne Health Group lobbied for Hackensack Meridian Health , earning $40,000. The report was filed on April 19, 2023.
Original Filing: 301458450.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, and surprise medical billing. H.R.2389, Resident Physician Shortage Reduction Act of 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2022
In Q4, Wynne Health Group lobbied for Hackensack Meridian Health , earning $40,000. The report was filed on Jan. 13, 2023.
Original Filing: 301427383.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, surprise medical billing, and COVID-19 response. H.R.2617, Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. H.R.6000, Cures 2.0 Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2022
In Q3, Wynne Health Group lobbied for Hackensack Meridian Health , earning $40,000. The report was filed on Oct. 12, 2022.
Original Filing: 301403009.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, surprise medical billing, and COVID-19 response;
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); H.R. 5376, FY 2022 Budget Reconciliation; and H.R.2471, Consolidated Appropriations Act, 2022 (P.L. 117-103).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. H.R.6000, Cures 2.0 Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2022
In Q2, Wynne Health Group lobbied for Hackensack Meridian Health , earning $40,000. The report was filed on July 15, 2022.
Original Filing: 301380664.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, surprise medical billing, and COVID-19 response;
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); H.R. 5376, FY 2022 Budget Reconciliation; and H.R.2471, Consolidated Appropriations Act, 2022 (P.L. 117-103).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. H.R.6000, Cures 2.0 Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2022
In Q1, Wynne Health Group lobbied for Hackensack Meridian Health , earning $40,000. The report was filed on April 18, 2022.
Original Filing: 301359459.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, provider workforce, value-based purchasing programs, post-acute care, telehealth, surprise medical billing, and COVID-19 response;
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); H.R. 5376, FY 2022 Budget Reconciliation; and H.R.2471, Consolidated Appropriations Act, 2022 (P.L. 117-103).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. H.R.6000, Cures 2.0 Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2021
In Q4, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on Jan. 14, 2022.
Original Filing: 301322724.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, value-based purchasing programs, post-acute care, inclusion of unique device identifiers on claims, telehealth, surprise medical billing, and COVID-19 response;
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2021
In Q3, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on Oct. 16, 2021.
Original Filing: 301300370.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, value-based purchasing programs, post-acute care, inclusion of unique device identifiers on claims, telehealth, surprise medical billing, and COVID-19 response;
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2021
In Q2, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on July 16, 2021.
Original Filing: 301277607.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, value-based purchasing programs, post-acute care, inclusion of unique device identifiers on claims, telehealth, surprise medical billing, and COVID-19 response;
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2021
In Q1, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on April 20, 2021.
Original Filing: 301260004.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, value-based purchasing programs, post-acute care, inclusion of unique device identifiers on claims, telehealth, surprise medical billing, and COVID-19 response;
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2020
In Q4, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on Jan. 19, 2021.
Original Filing: 301236934.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, value-based purchasing programs, post-acute care, inclusion of unique device identifiers on claims, telehealth, surprise medical billing, and COVID-19 response;
S.348/H.R.1763, Resident Physician Shortage Reduction Act of 2019;
H.R.6800, The HEROES Act;
H.R.7292, Hospital Pandemic Related Loan Forgiveness (To amend title XVIII of the Social Security Act to provide for forgiveness of certain accelerated and advance payments under parts A and B of the Medicare program).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2020
In Q3, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on Oct. 16, 2020.
Original Filing: 301212233.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, value-based purchasing programs, post-acute care, inclusion of unique device identifiers on claims, telehealth, surprise medical billing, and COVID-19 response;
S.348/H.R.1763, Resident Physician Shortage Reduction Act of 2019;
H.R.6800, The HEROES Act;
H.R.7292, Hospital Pandemic Related Loan Forgiveness (To amend title XVIII of the Social Security Act to provide for forgiveness of certain accelerated and advance payments under parts A and B of the Medicare program).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2020
In Q2, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on July 17, 2020.
Original Filing: 301192585.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, graduate medical education, value-based purchasing programs, post-acute care, inclusion of unique device identifiers on claims, telehealth, surprise medical billing, and COVID-19 response;
S.348/H.R.1763, Resident Physician Shortage Reduction Act of 2019;
H.R.6800, The HEROES Act;
H.R.7292, Hospital Pandemic Related Loan Forgiveness (To amend title XVIII of the Social Security Act to provide for forgiveness of certain accelerated and advance payments under parts A and B of the Medicare program).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2020
In Q1, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on April 18, 2020.
Original Filing: 301171800.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers on claims;
S.348/H.R.1763, Resident Physician Shortage Reduction Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2019
In Q4, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on Jan. 17, 2020.
Original Filing: 301110650.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers on claims;
S.348/H.R.1763, Resident Physician Shortage Reduction Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2019
In Q3, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on Oct. 16, 2019.
Original Filing: 301067163.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers on claims;
S.348/H.R.1763, Resident Physician Shortage Reduction Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2019
In Q2, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on July 19, 2019.
Original Filing: 301050124.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers on claims;
S.348/H.R.1763, Resident Physician Shortage Reduction Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2019
In Q1, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on April 19, 2019.
Original Filing: 301031291.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers on claims;
S.348/H.R.1763, Resident Physician Shortage Reduction Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2018
In Q4, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on Jan. 18, 2019.
Original Filing: 301010261.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers on claims;
H.R.2267/S.1301, Resident Physician Shortage Reduction Act of 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2018
In Q3, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on Oct. 17, 2018.
Original Filing: 300987174.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers on claims;
H.R.2267/S.1301, Resident Physician Shortage Reduction Act of 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2018
In Q2, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on July 17, 2018.
Original Filing: 300965840.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers on claims;
H.R.2267/S.1301, Resident Physician Shortage Reduction Act of 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2018
In Q1, Wynne Health Group lobbied for Hackensack Meridian Health , earning $30,000. The report was filed on April 19, 2018.
Original Filing: 300948410.xml
Lobbying Issues
Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers on claims; H.R.2267/S.1301, Resident Physician Shortage Reduction Act of 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to research funding, NIH and other matters.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2018
Wynne Health Group filed a lobbying registration on Jan. 16, 2018 to represent Hackensack Meridian Health, effective Jan. 1, 2018.
Original Filing: 300923961.xml
Issue(s) they said they’d lobby about: Issues related to hospital and other provider-related reimbursement, including: graduate medical education, value-based purchasing programs, post acute care, and inclusion of unique device identifiers on claims. Issues related to research funding, NIH and other matters. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...